Rankings
▼
Calendar
BMRN Q3 2016 Earnings — BioMarin Pharmaceutical Inc. Revenue & Financial Results | Market Cap Arena
BMRN
BioMarin Pharmaceutical Inc.
$12B
Q3 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$280M
Gross Profit
$229M
81.9% margin
Operating Income
-$60M
-21.5% margin
Net Income
-$37M
-13.4% margin
EPS (Diluted)
$-0.26
QoQ Revenue Growth
-6.7%
Cash Flow
Operating Cash Flow
-$11M
Free Cash Flow
-$37M
Stock-Based Comp.
$33M
Balance Sheet
Total Assets
$3.8B
Total Liabilities
$1.2B
Stockholders' Equity
$2.6B
Cash & Equivalents
$707M
Revenue Segments
Product Three
$91M
33%
Product One
$81M
29%
Product Two
$78M
28%
Product Four
$24M
9%
Product Five
$5M
2%
Geographic Segments
UNITED STATES
$130M
47%
Europe
$63M
22%
Rest Of World
$48M
17%
Latin America
$39M
14%
← FY 2016
All Quarters
Q4 2016 →
